Picture of Energenesis Biomedical Co logo

6657 Energenesis Biomedical Co Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Energenesis Biomedical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-129-120-266-260-231
Depreciation
Amortisation
Non-Cash Items4.073.187.384.92.54
Unusual Items
Other Non-Cash Items
Changes in Working Capital6.52-3.131.046.6125
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-98.9-97.3-233-225-181
Capital Expenditures-2.71-8.9-6.59-0.844-0.754
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items62.2-107182-58.1194
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities59.4-116175-59193
Financing Cash Flow Items0.127
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.77288-1.75440145
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-34.774.9-59.2156158